In Japan, after a drug quality audit, corrective actions typically follow a structured timeline. Initial responses are expected within 30 days, with a detailed corrective action plan submitted within 60 days. Implementation and verification of corrective actions should be completed within 6 months, ensuring compliance with regulatory standards and quality improvement.
